Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Paulina Zukowska"'
Autor:
Patricia M. Taylor, Paulina Zukowska, Magdi H. Yacoub, Marialuisa Lavitrano, Albert Heacox, Steven Goldstein, Zain Khalpey, Ryszard T. Smolenski, Adrian H. Chester, Ewa M. Slominska, Barbara Kutryb-Zajac, Ada H.Y. Yuen
Publikováno v:
Journal of Cardiovascular Translational Research
Extracellular nucleotide metabolism controls thrombosis and inflammation and may affect degeneration and calcification of aortic valve prostheses. We evaluated the effect of different decellularization strategies on enzyme activities involved in extr
Autor:
Barbara Kutryb-Zajac, Magdalena A. Zabielska, T. Borkowski, Paulina Zukowska, Ryszard T. Smolenski, Zain Khalpey, Agnieszka Jasztal, Marta Toczek, Ewa M. Slominska
Aortic stenosis is known to involve inflammation and thrombosis. Changes in activity of extracellular enzyme - ecto-5'-nucleotidase (referred also as CD73) can alter inflammatory and thrombotic responses. This study aimed to evaluate the effect of CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e06bbfb1af9f5080da7b6b666a1c73e
https://ruj.uj.edu.pl/xmlui/handle/item/262651
https://ruj.uj.edu.pl/xmlui/handle/item/262651
Autor:
Paulina Zukowska, Michal Mielcarek, Marta Toczek, Ryszard T. Smolenski, Mark Isalan, Barbara Kutryb-Zajac, Ewa M. Slominska
Publikováno v:
Nucleosides, nucleotidesnucleic acids. 35(10-12)
Huntington's disease (HD) is a monogenic neurodegenerative disorder with a significant peripheral component to the disease pathology. This includes an HD-related cardiomyopathy, with an unknown pathological mechanism. In this study, we aimed to defin
Autor:
Daniel Zielonka, Ryszard T. Smolenski, Jerzy T. Marcinkowski, Ewa M. Slominska, Paulina Zukowska, Marta Toczek, Mark Isalan, Michal Mielcarek
Publikováno v:
Biochimica et biophysica acta. 1862(11)
Huntington's disease (HD) is mainly thought of as a neurological disease, but multiple epidemiological studies have demonstrated a number of cardiovascular events leading to heart failure in HD patients. Our recent studies showed an increased risk of
Autor:
Barbara Sitek, Marta Toczek, Lukasz Mateuszuk, Barbara Kutryb-Zajac, Romuald Lango, Jan Rogowski, Agnieszka Zakrzewska, Ewa M. Slominska, Agnieszka Jasztal, Ryszard T. Smolenski, Patrycja Jablonska, Magdalena A. Zabielska, Paulina Zukowska, Stefan Chlopicki
Aims Extracellular nucleotides and adenosine that are formed or degraded by membrane-bound ecto-enzymes could affect atherosclerosis by regulating the inflammation and thrombosis. This study aimed to evaluate a relation between ecto-enzymes that conv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d417a6282b5a25ffe157c584739a7c1c
http://ruj.uj.edu.pl/xmlui/handle/item/36823
http://ruj.uj.edu.pl/xmlui/handle/item/36823
Publikováno v:
Pharmacological reports : PR. 67(4)
Ecto-5′-nucleotidase (e5NT, CD73) is an enzyme that is highly expressed in endothelium and is involved in the extracellular nucleotide catabolism. CD73 converts AMP to adenosine that via specific subtypes of P1 receptor mediates cytoprotection invo
Autor:
Marcin Lipiński, Ewa M. Slominska, Ryszard T. Smolenski, Marta Toczek, Barbara Kutryb-Zajac, Magdalena A. Zabielska, Paulina Zukowska, Stefan Chlopicki, Iwona Rybakowska
Atherosclerosis is a consequence of diverse pathologies that could be affected by signaling mediated by nucleotides and their metabolites. Concentration of specific nucleotide derivatives in the proximity of purinergic receptors is controlled by extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0724e2ddd01150f06d1ac47647b78fcd
http://ruj.uj.edu.pl/xmlui/handle/item/14302
http://ruj.uj.edu.pl/xmlui/handle/item/14302
Autor:
Małgorzata Edyta Wojtyś, Kajetan Kiełbowski, Michał Kunc, Seweryn Adam Skrzyniarz, Piotr Lisowski, Rafał Becht, Paulina Żukowska, Konrad Ptaszyński, Janusz Wójcik
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 283 (2023)
Basal cell carcinoma (BCC) is the most frequent human skin cancer, but metastasizing BCC (MBCC) is extremely rare, developing in approximately 0.0028% to 0.55% of BCC patients. Herein, we report two cases of pulmonary MBCC. The first one developed in
Externí odkaz:
https://doaj.org/article/220a50f84d944f96bace2d8b41f52c80